Anika Therapeutics Inc (ANIK)

R&D Expenses

$27.45M

TTM · Period ending: · USD

ANIK logo

ANIK R&D Expenses

Latest reported$27.45M
ANIK TTM R&D Expenses ($1.60M → $27.45M)
High-resolution chart · PNG

ANIK r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Anika Therapeutics Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
27,452,000
26,424,000
25,770,000
22,056,000
22,354,000
22,723,000
24,828,000
29,675,000
30,222,000
32,454,000
32,690,000
32,854,000
32,364,000
30,425,000
28,182,000
26,433,000
26,805,000
27,123,000
27,327,000
28,959,000
26,503,000
23,742,000
23,431,000
19,883,000
18,824,000
18,457,000
16,665,000
16,645,000
16,719,000
17,287,000
18,190,000
18,392,000
20,002,000
19,718,000
18,787,000
17,480,000
14,460,000
12,803,000
10,732,000
10,789,000
10,028,689
9,049,009
8,987,771
7,955,183
7,893,361
7,954,199
8,144,152
8,190,641
7,808,786
7,764,680
7,059,875
6,369,651
5,968,725
5,437,843
5,388,036
5,579,121
5,893,390
6,169,375
6,168,936
6,025,887
6,269,155
6,531,653
6,874,633
6,805,769
7,413,292
7,862,868
8,181,532
9,307,212
8,726,627
8,085,017
7,399,049
6,349,922
5,674,187
5,025,619
4,364,620
3,473,695
3,253,158
3,386,984
3,616,435
4,204,958
4,278,669
4,609,792
4,732,000
4,706,000
4,715,000
4,379,000
4,087,000
3,676,000
3,170,000
2,693,000
2,595,000
2,727,293
3,244,430
3,646,856
3,927,730
4,324,384
4,151,625
4,022,524
4,280,520
3,618,421
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.